159 related articles for article (PubMed ID: 11768727)
1. Cilnidipine more highly attenuates cold pressor stress-induced platelet activation in hypertension than does amlodipine.
Tomiyama H; Kimura Y; Kuwabara Y; Maruyama C; Yoshida Y; Kuwata S; Kinouchi T; Yoshida H; Doba N
Hypertens Res; 2001 Nov; 24(6):679-84. PubMed ID: 11768727
[TBL] [Abstract][Full Text] [Related]
2. Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension.
Sakata K; Shirotani M; Yoshida H; Nawada R; Obayashi K; Togi K; Miho N
Hypertension; 1999 Jun; 33(6):1447-52. PubMed ID: 10373231
[TBL] [Abstract][Full Text] [Related]
3. L/T-type and L/N-type calcium-channel blockers attenuate cardiac sympathetic nerve activity in patients with hypertension.
Ogura C; Ono K; Miyamoto S; Ikai A; Mitani S; Sugimoto N; Tanaka S; Fujita M
Blood Press; 2012 Dec; 21(6):367-71. PubMed ID: 22747420
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the anti-hypertensive effects of the L/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease.
Takei K; Araki N; Ohkubo T; Tamura N; Yamamoto T; Furuya D; Yanagisawa CT; Shimazu K
Intern Med; 2009; 48(16):1357-61. PubMed ID: 19687579
[TBL] [Abstract][Full Text] [Related]
5. Renoprotective and antioxidant effects of cilnidipine in hypertensive patients.
Soeki T; Kitani M; Kusunose K; Yagi S; Taketani Y; Koshiba K; Wakatsuki T; Orino S; Kawano K; Sata M
Hypertens Res; 2012 Nov; 35(11):1058-62. PubMed ID: 22763473
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats.
Aritomi S; Harada E; Sugino K; Nishimura M; Nakamura T; Takahara A
Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):344-52. PubMed ID: 25582553
[TBL] [Abstract][Full Text] [Related]
7. Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension.
Takami T; Shigematsu M
Clin Exp Hypertens; 2003 Nov; 25(8):525-35. PubMed ID: 14649310
[TBL] [Abstract][Full Text] [Related]
8. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
[TBL] [Abstract][Full Text] [Related]
9. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
Morimoto S; Yano Y; Maki K; Iwasaka T
J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
[TBL] [Abstract][Full Text] [Related]
10. Reduction of white coat effect by cilnidipine in essential hypertension.
Morimoto S; Takeda K; Oguni A; Kido H; Harada S; Moriguchi J; Itoh H; Nakata T; Sasaki S; Nakagawa M
Am J Hypertens; 2001 Oct; 14(10):1053-7. PubMed ID: 11710785
[TBL] [Abstract][Full Text] [Related]
11. Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel.
Shimizu H; Nakagami H; Yasumasa N; Mariana OK; Kyutoku M; Koriyama H; Nakagami F; Shimamura M; Rakugi H; Morishita R
Hypertens Res; 2012 Jan; 35(1):77-81. PubMed ID: 21881574
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of L- and N-type calcium channel blocker on uric acid levels and left atrial volume in hypertensive patients.
Masaki M; Mano T; Eguchi A; Fujiwara S; Sugahara M; Hirotani S; Tsujino T; Komamura K; Koshiba M; Masuyama T
Heart Vessels; 2016 Nov; 31(11):1826-1833. PubMed ID: 26825736
[TBL] [Abstract][Full Text] [Related]
13. L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease.
Abe M; Maruyama N; Suzuki H; Inoshita A; Yoshida Y; Okada K; Soma M
Heart Vessels; 2013 Jul; 28(4):480-9. PubMed ID: 22914905
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of L- and N-type calcium channel blocker on glucose and lipid metabolism and renal function in patients with hypertension and type II diabetes mellitus.
Masuda T; Ogura MN; Moriya T; Takahira N; Matsumoto T; Kutsuna T; Hara M; Aiba N; Noda C; Izumi T
Cardiovasc Ther; 2011 Feb; 29(1):46-53. PubMed ID: 20337636
[TBL] [Abstract][Full Text] [Related]
15. Comparison between L-type and N/L-type calcium channel blockers in the regulation of home blood-pressure variability in elderly hypertensive patients.
Nozato S; Yamamoto K; Nozato Y; Takeda M; Hongyo K; Takeya M; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Ito N; Rakugi H
Hypertens Res; 2018 Apr; 41(4):290-298. PubMed ID: 29449705
[TBL] [Abstract][Full Text] [Related]
16. Reduction in microalbuminuria by calcium channel blockers in patients with type 2 diabetes mellitus and hypertension-A randomized, open-label, active-controlled, superiority, parallel-group clinical trial.
Hwang YC; Yoon KH; Cha BS; Lee KW; Jang HC; Min KW; Chung CH; Lee MK
Int J Clin Pract; 2017 Sep; 71(9):. PubMed ID: 28840637
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the antialbuminuric effects of L-/N-type and L-type calcium channel blockers in hypertensive patients with diabetes and microalbuminuria: the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial.
Ando K; Ueshima K; Tanaka S; Kosugi S; Sato T; Matsuoka H; Nakao K; Fujita T
Int J Med Sci; 2013; 10(9):1209-16. PubMed ID: 23935398
[TBL] [Abstract][Full Text] [Related]
18. Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension.
Minami J; Kawano Y; Makino Y; Matsuoka H; Takishita S
Br J Clin Pharmacol; 2000 Dec; 50(6):615-20. PubMed ID: 11136301
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure.
Hoshide S; Kario K; Ishikawa J; Eguchi K; Shimada K
Hypertens Res; 2005 Dec; 28(12):1003-8. PubMed ID: 16671340
[TBL] [Abstract][Full Text] [Related]
20. Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension.
Fogari R; Zoppi A; Corradi L; Preti P; Malalamani GD; Mugellini A
J Hypertens; 2000 Dec; 18(12):1871-5. PubMed ID: 11132613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]